The Canadian government has announced an investment of up to CAD35m ($26.6m, €24m) for the development and production of crucial medical radioisotopes in the country.
As part of the funding, indigenous group Saugeen Ojibway Nation will collaborate with Bruce Power, which supplies 30% of Ontario’s power through its eight-unit Bruce nuclear station, to jointly produce and market new radioisotopes.
Bruce Power already supplies cobalt-60 for sterilising medical devices, but is aiming to increase production of lutetium-177 (Lu-177), which is used in advanced prostate cancer treatment.